A Phase 2 Study to Evaluate Safety and Efficacy of EB-001 Injections in Facial Scar Reduction After Undergoing Mohs Surgery
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Botulinum toxin E (Primary)
- Indications Scars
- Focus Proof of concept; Therapeutic Use
- Acronyms SHINE-1
- Sponsors Bonti
- 08 Feb 2018 According to a Bonti media release, the first patient from this trial has been dosed.
- 06 Feb 2018 Status changed from not yet recruiting to recruiting.
- 22 Nov 2017 New trial record